Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States
Autore:
Fatica, RA; Port, FK; Young, EW;
Indirizzi:
Cleveland Clin Fdn, Dept Hypertens & Nephrol, Cleveland, OH 44195 USA Cleveland Clin Fdn Cleveland OH USA 44195 ephrol, Cleveland, OH 44195 USA Univ Michigan, Med Ctr, Dept Med, Ann Arbor, MI 48109 USA Univ Michigan Ann Arbor MI USA 48109 r, Dept Med, Ann Arbor, MI 48109 USA Univ Michigan, Med Ctr, Dept Epidemiol, Ann Arbor, MI 48109 USA Univ Michigan Ann Arbor MI USA 48109 t Epidemiol, Ann Arbor, MI 48109 USA Vet Adm Med Ctr, Div Nephrol, Dept Internal Med, Ann Arbor, MI 48105 USA Vet Adm Med Ctr Ann Arbor MI USA 48105 ernal Med, Ann Arbor, MI 48105 USA
Titolo Testata:
AMERICAN JOURNAL OF KIDNEY DISEASES
fascicolo: 6, volume: 37, anno: 2001,
pagine: 1184 - 1190
SICI:
0272-6386(200106)37:6<1184:ITAMIE>2.0.ZU;2-2
Fonte:
ISI
Lingua:
ENG
Soggetto:
ARTERY STENOSIS; NATURAL-HISTORY; HYPERTENSION; NEPHROPATHY; INSIGHTS;
Keywords:
end-stage renal disease (ESRD); chronic kidney failure; renovascular disease (RVD); renal artery stenosis;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
22
Recensione:
Indirizzi per estratti:
Indirizzo: Fatica, RA Cleveland Clin Fdn, Dept Hypertens & Nephrol, 9500 Euclid Ave, Cleveland, OH 44195 USA Cleveland Clin Fdn 9500 Euclid Ave Cleveland OH USA44195 5 USA
Citazione:
R.A. Fatica et al., "Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States", AM J KIDNEY, 37(6), 2001, pp. 1184-1190

Abstract

End-stage renal disease (ESRD) attributed to renovascular disease (RVD-ESRD) has been incompletely characterized. We determined incidence trends, clinical features, prior treatment, and survival of patients with RVD-ESRD using the US Renal Data System database. Primary causes of ESRD were assessed in patients starting ESRD therapy during 1991 to 1997. The incidence of RVD-ESRD increased from 2.9/10(6) per year (1.4% of new ESRD cases) to 6.1/10(6) per year (2.1%). The annualized increase was 12.4% per year. This is a greater rate of increase than for ESRD from diabetes mellitis (DM-ESRD; 8.3%per year) and ESRD overall (5.4% per year). The risk for RVD-ESRD versus other cause ESRD correlated positively with age (odds ratio [OR], 1.7 per 10-year increment; P < 0.0001) and male sex (OR, 1.2; P < 0.0001) and negatively with black (OR, 0.17; P < 0.0001), Asian (OR, 0.29; P < 0.0001), and Native American race (OR, 0.31; P < 0.0001). The unadjusted prevalence of coronary heart disease, cerebrovascular disease, and peripheral vascular disease was greater in patients with RVD-ESRD versus other-cause ESRD (P < 0.001). Of patients with RVD-ESRD, 5% underwent revascularization in the 2 yearsbefore ESRD compared with 0.5% of patients with other-cause ESRD, including DM-ESRD, Adjusted for age, race, sex, comorbidity, and laboratory values,the survival of patients with RVD-ESRD was similar to that for patients with other cause ESRD (risk ratio, 1.01; P = 0.5). These findings suggest that RVD-ESRD is increasing faster than other-cause ESRD and is not independently associated with an increased mortality risk. Strategies may exist to prevent progression to ESRD and merit priority for further study, (C) 2001 bythe National Kidney Foundation, Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/12/20 alle ore 22:29:12